Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 4/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.49 |
| ▸ | HPGD | P15428 | 6/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 3/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL935583 | 0.87 | ADORA2A (0.61) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL12163763 | 0.80 | ADORA1 (0.51) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL12553020 | 0.80 | ADORA1 (0.56) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL7013023 | 0.79 | ADORA3 (0.65) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL6461004 | 0.76 | KDM4E (0.70) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| Hydrochloric Acid SCHEMBL7021740 | 0.75 | KDM4E (0.68) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL15286738 | 0.75 | ADORA1 (0.43) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL3602052 | 0.74 | ADORA1 (0.58) | ADORA1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL7011406 | 0.73 | ADORA2A (0.70) | ADORA1KDM4EHSD17B10HPGDRXFP1 | |
| SCHEMBL14872208 | 0.73 | ADORA2A (0.49) | ADORA1KDM4EHSD17B10HPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030232860-A1 | Medicine comprising dicyanopyridine derivative | ASTELLAS PHARMA INC. (JP) | 2003-12-18 | — | — | US | disclosed |
| EP-1302463-A1 | MEDICINE COMPRISING DICYANOPYRIDINE DERIVATIVE | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2003-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232860-A1 | Medicine comprising dicyanopyridine derivative | KCNN3, KCNN2, KCNN1 | ADORA1 1628/4885KDM4E 369/4885HSD17B10 3642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.